Certara Appoints John Reynders as New Independent Board Member
Provided By GlobeNewswire
Last update: Oct 16, 2024
RADNOR, Pa., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the appointment of John Reynders, PhD, to its Board of Directors, effective October 15, 2024.
